The use of statistical mune in a multicenter clinical trial

Muscle and Nerve

Volumn 30, Issue 4, 2004, Pages 463-469

  Shefner, J M ^a   Cudkowicz, M E ^b   Zhang, H ^b   Schoenfeld, D ^a   Jillapalli, D ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amyotrophic lateral sclerosis; Clinical trial; Motor unit; Motor unit number estimation; Statistical MUNE

Indexed keywords

CREATINE; PLACEBO;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MONITORING; MOTOR UNIT; MULTICENTER STUDY; MUSCLE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TECHNIQUE;

ACTION POTENTIALS; AMYOTROPHIC LATERAL SCLEROSIS; CELL COUNT; CREATINE; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; HUMANS; MOTOR NEURONS; MUSCLE, SKELETAL; OBSERVER VARIATION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 4644243244     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20120     Document Type: Article

References (22)

1. Armon C, Brandstater ME. Motor unit number estimate-based rates of progression of ALS predict patient survival. Muscle Nerve 1999;22:1571-1575.
2. Bromberg MB. Motor unit estimation: reproducibility of the spike-triggered averaging technique in normal and ALS subjects. Muscle Nerve 1993;16:466-471.
3. Bromberg MB, Jaros L. Symmetry of normal motor and sensory nerve conduction measurements. Muscle Nerve 1998;21: 498-503.
4. Cudkowicz M, Qureshi M, Shefner J. Measures and markers in amyotrophic lateral sclerosis. J Am Soc Exp Ther 2004;1:273-283.
5. Cudkowicz ME, Shefner JM, Schoenfeld DA, Brown RH Jr., Johnson H, Qureshi M, Jacobs M, Rothstein JD, Appel SH, Pascuzzi RM, Heiman Patterson TD, Donofrio PD, David WS, Russell JA, Tandan R, Pioro EP, Felice KJ, Rosenfeld J, Mandler RN, Sachs GM, Bradley WG, Raynor EM, Baquis GD, Belsh JM, Novella S, Goldstein J, Hulihan J. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology 2003;61:456-464.
6. Dantes M, McComas A. The extent and time course of motoneuron involvement in amyotrophic lateral sclerosis. Muscle Nerve 1991;7:416-421.
7. Daube JR. Estimating the number of motor units in a muscle. J Clin Neurophysiol 1995;12:585-594.
8. Dengler R, Konstanzer A, Kuther G, Hesse S, Wolf W, Struppler A. Amyotrophic lateral sclerosis: macro-EMG and twitch forces of single motor units. Muscle Nerve 1990;13:545-550.
9. Erminio F, Buchthal F, Rosenfalk P. Motor unit territory and muscle fiber concentration in paresis due to peripheral nerve injury and anterior horn involvement. Neurology 1959;9:657-671.
10. Felice KJ. A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis. Muscle Nerve 1997;20:179-185.
11. Gooch C, Harati Y. Motor unit number estimation, ALS, and clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:71-82.
12. Krarup C, Buchthal F. Conduction studies in peripheral nerve. Neurobehav Toxicol Teratol 1985;7:319-323.
13. Lomen-Hoerth C, Olney RK. Comparison of multiple point and statistical motor unit number estimation. Muscle Nerve 2000;23:1525-1533.
14. Lomen-Hoerth C, Olney RK. Effect of recording window and stimulation variables on the statistical technique of motor unit number estimation. Muscle Nerve 2001;24:1659-1664.
15. Lomen-Hoerth C, Slawnych MP. Statistical motor unit number estimation: from theory to practice. Muscle Nerve 2003; 28:263-272.
16. Olney R, Yuen E, Engstrom J. The rate of change in motor unit number estimates predicts survival in patients with amyotrophic lateral sclerosis. Neurology 1999;52 (Suppl 2):A3.
17. Olney RK, Yuen EC, Engstrom JW. Statistical motor unit number estimation: reproducibility and sources of error in patients with amyotrophic lateral sclerosis. Muscle Nerve 2000;23:193-197.
18. Shefner J, Brown RJ, Cole D, Chaturvedi P, Schoenfeld D, Pastuszak K, Matthews R, Upton-Rice M, Cudkowicz ME. Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations. Neurology 2001;57:1857-1861.
19. Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Pestronk A, Caress J, Sorenson E, Bradley W, Lomen-Hoerth C, Pioro E, Rezania K, Ross M, Pascuzzi R, Heiman-Patterson T, Tandan R, Mitsumoto H, Rothstein J, and the NEALS Consortium. A clinical trial of creatine in patients with amyotrophic lateral sclerosis. Presented at the 14th Annual International Symposium on ALS/ MND, Milan, Italy, 2003.
20. Shefner JM, Jillapalli D, Bradshaw DY. Reducing intersubject variability in motor unit number estimation. Muscle Nerve 1999;22:1457-1460.
21. Shefner JM, Reaume AG, Flood DG, Scott RW, Kowall NW, Ferrante RJ, Siwak DF, Upton-Rice M, Brown RH Jr. Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology 1999;53:1239-1246.
22. Smith B, Clarke J, Litchy W, Daube JR, Olney RK, Yuen EC, Bromberg M. Longitudinal electrodiagnostic studies in ALS patients treated with recombinant human ciliary neurotrophic factor. Neurology 1995;45:A448.